Global Trastuzumab Injection Market Growth 2026-2032
The global Trastuzumab Injection market size is predicted to grow from US$ 865 million in 2025 to US$ 1250 million in 2032; it is expected to grow at a CAGR of 5.5% from 2026 to 2032.
Trastuzumab is a targeted cancer drug and is also known by other names such as Herceptin, Herzuma and Ontruzant. It is a treatment for early and advanced breast cancer, advanced stomach cancer and cancer of where the food pipe joins your stomach (gastro oesophageal junction). Trastuzumab injection products are used with other medications or after other medications have been used to treat a certain type of breast cancer that has spread to other parts of the body. Trastuzumab injection products are also used during and after treatment with other medications to decrease the chance that a certain type of breast cancer will return. Trastuzumab injection products are also used with other medications to treat certain types of stomach cancer that have spread to other parts of the body. Trastuzumab is in a class of medications called monoclonal antibodies. It works by stopping the growth of cancer cells.
United States market for Trastuzumab Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Trastuzumab Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Trastuzumab Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Trastuzumab Injection players cover Pfizer, Roche, Celltrion, Amgen, Samsung Bioepsis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Trastuzumab Injection Industry Forecast? looks at past sales and reviews total world Trastuzumab Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Trastuzumab Injection sales for 2026 through 2032. With Trastuzumab Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Trastuzumab Injection industry.
This Insight Report provides a comprehensive analysis of the global Trastuzumab Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Trastuzumab Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Trastuzumab Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Trastuzumab Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Trastuzumab Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Trastuzumab Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Trastuzumab is a targeted cancer drug and is also known by other names such as Herceptin, Herzuma and Ontruzant. It is a treatment for early and advanced breast cancer, advanced stomach cancer and cancer of where the food pipe joins your stomach (gastro oesophageal junction). Trastuzumab injection products are used with other medications or after other medications have been used to treat a certain type of breast cancer that has spread to other parts of the body. Trastuzumab injection products are also used during and after treatment with other medications to decrease the chance that a certain type of breast cancer will return. Trastuzumab injection products are also used with other medications to treat certain types of stomach cancer that have spread to other parts of the body. Trastuzumab is in a class of medications called monoclonal antibodies. It works by stopping the growth of cancer cells.
United States market for Trastuzumab Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Trastuzumab Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Trastuzumab Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Trastuzumab Injection players cover Pfizer, Roche, Celltrion, Amgen, Samsung Bioepsis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Trastuzumab Injection Industry Forecast? looks at past sales and reviews total world Trastuzumab Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Trastuzumab Injection sales for 2026 through 2032. With Trastuzumab Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Trastuzumab Injection industry.
This Insight Report provides a comprehensive analysis of the global Trastuzumab Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Trastuzumab Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Trastuzumab Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Trastuzumab Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Trastuzumab Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Trastuzumab Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 60 mg
- 150 mg
- 440 mg
- Others
- Hospitals
- Clinics
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Roche
- Celltrion
- Amgen
- Samsung Bioepsis
- Mylan
- Glenmark
- AstraZeneca
- Remegen Co., Ltd.
- Hisun Biopharmaceutical
- Shanghai Henlius Biotech
- What is the 10-year outlook for the global Trastuzumab Injection market?
- What factors are driving Trastuzumab Injection market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Trastuzumab Injection market opportunities vary by end market size?
- How does Trastuzumab Injection break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Trastuzumab Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Trastuzumab Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Trastuzumab Injection by Country/Region, 2021, 2025 & 2032
2.2 Trastuzumab Injection Segment by Type
2.2.1 60 mg
2.2.2 150 mg
2.2.3 440 mg
2.2.4 Others
2.2.5 Trastuzumab Injection Sales by Type
2.2.5.1 Global Trastuzumab Injection Sales Market Share by Type (2021-2026)
2.2.5.2 Global Trastuzumab Injection Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Trastuzumab Injection Sale Price by Type (2021-2026)
2.3 Trastuzumab Injection Segment by Application
2.3.1 Hospitals
2.3.2 Clinics
2.3.3 Others
2.3.4 Trastuzumab Injection Sales by Application
2.3.4.1 Global Trastuzumab Injection Sale Market Share by Application (2021-2026)
2.3.4.2 Global Trastuzumab Injection Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Trastuzumab Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Trastuzumab Injection Breakdown Data by Company
3.1.1 Global Trastuzumab Injection Annual Sales by Company (2021-2026)
3.1.2 Global Trastuzumab Injection Sales Market Share by Company (2021-2026)
3.2 Global Trastuzumab Injection Annual Revenue by Company (2021-2026)
3.2.1 Global Trastuzumab Injection Revenue by Company (2021-2026)
3.2.2 Global Trastuzumab Injection Revenue Market Share by Company (2021-2026)
3.3 Global Trastuzumab Injection Sale Price by Company
3.4 Key Manufacturers Trastuzumab Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Trastuzumab Injection Product Location Distribution
3.4.2 Players Trastuzumab Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TRASTUZUMAB INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Trastuzumab Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Trastuzumab Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Trastuzumab Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Trastuzumab Injection Market Size by Country/Region (2021-2026)
4.2.1 Global Trastuzumab Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Trastuzumab Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Trastuzumab Injection Sales Growth
4.4 APAC Trastuzumab Injection Sales Growth
4.5 Europe Trastuzumab Injection Sales Growth
4.6 Middle East & Africa Trastuzumab Injection Sales Growth
5 AMERICAS
5.1 Americas Trastuzumab Injection Sales by Country
5.1.1 Americas Trastuzumab Injection Sales by Country (2021-2026)
5.1.2 Americas Trastuzumab Injection Revenue by Country (2021-2026)
5.2 Americas Trastuzumab Injection Sales by Type (2021-2026)
5.3 Americas Trastuzumab Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Trastuzumab Injection Sales by Region
6.1.1 APAC Trastuzumab Injection Sales by Region (2021-2026)
6.1.2 APAC Trastuzumab Injection Revenue by Region (2021-2026)
6.2 APAC Trastuzumab Injection Sales by Type (2021-2026)
6.3 APAC Trastuzumab Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Trastuzumab Injection by Country
7.1.1 Europe Trastuzumab Injection Sales by Country (2021-2026)
7.1.2 Europe Trastuzumab Injection Revenue by Country (2021-2026)
7.2 Europe Trastuzumab Injection Sales by Type (2021-2026)
7.3 Europe Trastuzumab Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Trastuzumab Injection by Country
8.1.1 Middle East & Africa Trastuzumab Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Trastuzumab Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Trastuzumab Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Trastuzumab Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Trastuzumab Injection
10.3 Manufacturing Process Analysis of Trastuzumab Injection
10.4 Industry Chain Structure of Trastuzumab Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Trastuzumab Injection Distributors
11.3 Trastuzumab Injection Customer
12 WORLD FORECAST REVIEW FOR TRASTUZUMAB INJECTION BY GEOGRAPHIC REGION
12.1 Global Trastuzumab Injection Market Size Forecast by Region
12.1.1 Global Trastuzumab Injection Forecast by Region (2027-2032)
12.1.2 Global Trastuzumab Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Trastuzumab Injection Forecast by Type (2027-2032)
12.7 Global Trastuzumab Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Trastuzumab Injection Product Portfolios and Specifications
13.1.3 Pfizer Trastuzumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Roche
13.2.1 Roche Company Information
13.2.2 Roche Trastuzumab Injection Product Portfolios and Specifications
13.2.3 Roche Trastuzumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Roche Main Business Overview
13.2.5 Roche Latest Developments
13.3 Celltrion
13.3.1 Celltrion Company Information
13.3.2 Celltrion Trastuzumab Injection Product Portfolios and Specifications
13.3.3 Celltrion Trastuzumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Celltrion Main Business Overview
13.3.5 Celltrion Latest Developments
13.4 Amgen
13.4.1 Amgen Company Information
13.4.2 Amgen Trastuzumab Injection Product Portfolios and Specifications
13.4.3 Amgen Trastuzumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Amgen Main Business Overview
13.4.5 Amgen Latest Developments
13.5 Samsung Bioepsis
13.5.1 Samsung Bioepsis Company Information
13.5.2 Samsung Bioepsis Trastuzumab Injection Product Portfolios and Specifications
13.5.3 Samsung Bioepsis Trastuzumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Samsung Bioepsis Main Business Overview
13.5.5 Samsung Bioepsis Latest Developments
13.6 Mylan
13.6.1 Mylan Company Information
13.6.2 Mylan Trastuzumab Injection Product Portfolios and Specifications
13.6.3 Mylan Trastuzumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Mylan Main Business Overview
13.6.5 Mylan Latest Developments
13.7 Glenmark
13.7.1 Glenmark Company Information
13.7.2 Glenmark Trastuzumab Injection Product Portfolios and Specifications
13.7.3 Glenmark Trastuzumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Glenmark Main Business Overview
13.7.5 Glenmark Latest Developments
13.8 AstraZeneca
13.8.1 AstraZeneca Company Information
13.8.2 AstraZeneca Trastuzumab Injection Product Portfolios and Specifications
13.8.3 AstraZeneca Trastuzumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 AstraZeneca Main Business Overview
13.8.5 AstraZeneca Latest Developments
13.9 Remegen Co., Ltd.
13.9.1 Remegen Co., Ltd. Company Information
13.9.2 Remegen Co., Ltd. Trastuzumab Injection Product Portfolios and Specifications
13.9.3 Remegen Co., Ltd. Trastuzumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Remegen Co., Ltd. Main Business Overview
13.9.5 Remegen Co., Ltd. Latest Developments
13.10 Hisun Biopharmaceutical
13.10.1 Hisun Biopharmaceutical Company Information
13.10.2 Hisun Biopharmaceutical Trastuzumab Injection Product Portfolios and Specifications
13.10.3 Hisun Biopharmaceutical Trastuzumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Hisun Biopharmaceutical Main Business Overview
13.10.5 Hisun Biopharmaceutical Latest Developments
13.11 Shanghai Henlius Biotech
13.11.1 Shanghai Henlius Biotech Company Information
13.11.2 Shanghai Henlius Biotech Trastuzumab Injection Product Portfolios and Specifications
13.11.3 Shanghai Henlius Biotech Trastuzumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Shanghai Henlius Biotech Main Business Overview
13.11.5 Shanghai Henlius Biotech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Trastuzumab Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Trastuzumab Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Trastuzumab Injection by Country/Region, 2021, 2025 & 2032
2.2 Trastuzumab Injection Segment by Type
2.2.1 60 mg
2.2.2 150 mg
2.2.3 440 mg
2.2.4 Others
2.2.5 Trastuzumab Injection Sales by Type
2.2.5.1 Global Trastuzumab Injection Sales Market Share by Type (2021-2026)
2.2.5.2 Global Trastuzumab Injection Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Trastuzumab Injection Sale Price by Type (2021-2026)
2.3 Trastuzumab Injection Segment by Application
2.3.1 Hospitals
2.3.2 Clinics
2.3.3 Others
2.3.4 Trastuzumab Injection Sales by Application
2.3.4.1 Global Trastuzumab Injection Sale Market Share by Application (2021-2026)
2.3.4.2 Global Trastuzumab Injection Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Trastuzumab Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Trastuzumab Injection Breakdown Data by Company
3.1.1 Global Trastuzumab Injection Annual Sales by Company (2021-2026)
3.1.2 Global Trastuzumab Injection Sales Market Share by Company (2021-2026)
3.2 Global Trastuzumab Injection Annual Revenue by Company (2021-2026)
3.2.1 Global Trastuzumab Injection Revenue by Company (2021-2026)
3.2.2 Global Trastuzumab Injection Revenue Market Share by Company (2021-2026)
3.3 Global Trastuzumab Injection Sale Price by Company
3.4 Key Manufacturers Trastuzumab Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Trastuzumab Injection Product Location Distribution
3.4.2 Players Trastuzumab Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TRASTUZUMAB INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Trastuzumab Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Trastuzumab Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Trastuzumab Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Trastuzumab Injection Market Size by Country/Region (2021-2026)
4.2.1 Global Trastuzumab Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Trastuzumab Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Trastuzumab Injection Sales Growth
4.4 APAC Trastuzumab Injection Sales Growth
4.5 Europe Trastuzumab Injection Sales Growth
4.6 Middle East & Africa Trastuzumab Injection Sales Growth
5 AMERICAS
5.1 Americas Trastuzumab Injection Sales by Country
5.1.1 Americas Trastuzumab Injection Sales by Country (2021-2026)
5.1.2 Americas Trastuzumab Injection Revenue by Country (2021-2026)
5.2 Americas Trastuzumab Injection Sales by Type (2021-2026)
5.3 Americas Trastuzumab Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Trastuzumab Injection Sales by Region
6.1.1 APAC Trastuzumab Injection Sales by Region (2021-2026)
6.1.2 APAC Trastuzumab Injection Revenue by Region (2021-2026)
6.2 APAC Trastuzumab Injection Sales by Type (2021-2026)
6.3 APAC Trastuzumab Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Trastuzumab Injection by Country
7.1.1 Europe Trastuzumab Injection Sales by Country (2021-2026)
7.1.2 Europe Trastuzumab Injection Revenue by Country (2021-2026)
7.2 Europe Trastuzumab Injection Sales by Type (2021-2026)
7.3 Europe Trastuzumab Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Trastuzumab Injection by Country
8.1.1 Middle East & Africa Trastuzumab Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Trastuzumab Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Trastuzumab Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Trastuzumab Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Trastuzumab Injection
10.3 Manufacturing Process Analysis of Trastuzumab Injection
10.4 Industry Chain Structure of Trastuzumab Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Trastuzumab Injection Distributors
11.3 Trastuzumab Injection Customer
12 WORLD FORECAST REVIEW FOR TRASTUZUMAB INJECTION BY GEOGRAPHIC REGION
12.1 Global Trastuzumab Injection Market Size Forecast by Region
12.1.1 Global Trastuzumab Injection Forecast by Region (2027-2032)
12.1.2 Global Trastuzumab Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Trastuzumab Injection Forecast by Type (2027-2032)
12.7 Global Trastuzumab Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Trastuzumab Injection Product Portfolios and Specifications
13.1.3 Pfizer Trastuzumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Roche
13.2.1 Roche Company Information
13.2.2 Roche Trastuzumab Injection Product Portfolios and Specifications
13.2.3 Roche Trastuzumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Roche Main Business Overview
13.2.5 Roche Latest Developments
13.3 Celltrion
13.3.1 Celltrion Company Information
13.3.2 Celltrion Trastuzumab Injection Product Portfolios and Specifications
13.3.3 Celltrion Trastuzumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Celltrion Main Business Overview
13.3.5 Celltrion Latest Developments
13.4 Amgen
13.4.1 Amgen Company Information
13.4.2 Amgen Trastuzumab Injection Product Portfolios and Specifications
13.4.3 Amgen Trastuzumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Amgen Main Business Overview
13.4.5 Amgen Latest Developments
13.5 Samsung Bioepsis
13.5.1 Samsung Bioepsis Company Information
13.5.2 Samsung Bioepsis Trastuzumab Injection Product Portfolios and Specifications
13.5.3 Samsung Bioepsis Trastuzumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Samsung Bioepsis Main Business Overview
13.5.5 Samsung Bioepsis Latest Developments
13.6 Mylan
13.6.1 Mylan Company Information
13.6.2 Mylan Trastuzumab Injection Product Portfolios and Specifications
13.6.3 Mylan Trastuzumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Mylan Main Business Overview
13.6.5 Mylan Latest Developments
13.7 Glenmark
13.7.1 Glenmark Company Information
13.7.2 Glenmark Trastuzumab Injection Product Portfolios and Specifications
13.7.3 Glenmark Trastuzumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Glenmark Main Business Overview
13.7.5 Glenmark Latest Developments
13.8 AstraZeneca
13.8.1 AstraZeneca Company Information
13.8.2 AstraZeneca Trastuzumab Injection Product Portfolios and Specifications
13.8.3 AstraZeneca Trastuzumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 AstraZeneca Main Business Overview
13.8.5 AstraZeneca Latest Developments
13.9 Remegen Co., Ltd.
13.9.1 Remegen Co., Ltd. Company Information
13.9.2 Remegen Co., Ltd. Trastuzumab Injection Product Portfolios and Specifications
13.9.3 Remegen Co., Ltd. Trastuzumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Remegen Co., Ltd. Main Business Overview
13.9.5 Remegen Co., Ltd. Latest Developments
13.10 Hisun Biopharmaceutical
13.10.1 Hisun Biopharmaceutical Company Information
13.10.2 Hisun Biopharmaceutical Trastuzumab Injection Product Portfolios and Specifications
13.10.3 Hisun Biopharmaceutical Trastuzumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Hisun Biopharmaceutical Main Business Overview
13.10.5 Hisun Biopharmaceutical Latest Developments
13.11 Shanghai Henlius Biotech
13.11.1 Shanghai Henlius Biotech Company Information
13.11.2 Shanghai Henlius Biotech Trastuzumab Injection Product Portfolios and Specifications
13.11.3 Shanghai Henlius Biotech Trastuzumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Shanghai Henlius Biotech Main Business Overview
13.11.5 Shanghai Henlius Biotech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Trastuzumab Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Trastuzumab Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 60 mg
Table 4. Major Players of 150 mg
Table 5. Major Players of 440 mg
Table 6. Major Players of Others
Table 7. Global Trastuzumab Injection Sales by Type (2021-2026) & (K Units)
Table 8. Global Trastuzumab Injection Sales Market Share by Type (2021-2026)
Table 9. Global Trastuzumab Injection Revenue by Type (2021-2026) & ($ million)
Table 10. Global Trastuzumab Injection Revenue Market Share by Type (2021-2026)
Table 11. Global Trastuzumab Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global Trastuzumab Injection Sale by Application (2021-2026) & (K Units)
Table 13. Global Trastuzumab Injection Sale Market Share by Application (2021-2026)
Table 14. Global Trastuzumab Injection Revenue by Application (2021-2026) & ($ million)
Table 15. Global Trastuzumab Injection Revenue Market Share by Application (2021-2026)
Table 16. Global Trastuzumab Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global Trastuzumab Injection Sales by Company (2021-2026) & (K Units)
Table 18. Global Trastuzumab Injection Sales Market Share by Company (2021-2026)
Table 19. Global Trastuzumab Injection Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Trastuzumab Injection Revenue Market Share by Company (2021-2026)
Table 21. Global Trastuzumab Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers Trastuzumab Injection Producing Area Distribution and Sales Area
Table 23. Players Trastuzumab Injection Products Offered
Table 24. Trastuzumab Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Trastuzumab Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global Trastuzumab Injection Sales Market Share Geographic Region (2021-2026)
Table 29. Global Trastuzumab Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Trastuzumab Injection Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Trastuzumab Injection Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global Trastuzumab Injection Sales Market Share by Country/Region (2021-2026)
Table 33. Global Trastuzumab Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Trastuzumab Injection Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Trastuzumab Injection Sales by Country (2021-2026) & (K Units)
Table 36. Americas Trastuzumab Injection Sales Market Share by Country (2021-2026)
Table 37. Americas Trastuzumab Injection Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Trastuzumab Injection Sales by Type (2021-2026) & (K Units)
Table 39. Americas Trastuzumab Injection Sales by Application (2021-2026) & (K Units)
Table 40. APAC Trastuzumab Injection Sales by Region (2021-2026) & (K Units)
Table 41. APAC Trastuzumab Injection Sales Market Share by Region (2021-2026)
Table 42. APAC Trastuzumab Injection Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Trastuzumab Injection Sales by Type (2021-2026) & (K Units)
Table 44. APAC Trastuzumab Injection Sales by Application (2021-2026) & (K Units)
Table 45. Europe Trastuzumab Injection Sales by Country (2021-2026) & (K Units)
Table 46. Europe Trastuzumab Injection Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Trastuzumab Injection Sales by Type (2021-2026) & (K Units)
Table 48. Europe Trastuzumab Injection Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa Trastuzumab Injection Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa Trastuzumab Injection Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Trastuzumab Injection Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa Trastuzumab Injection Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Trastuzumab Injection
Table 54. Key Market Challenges & Risks of Trastuzumab Injection
Table 55. Key Industry Trends of Trastuzumab Injection
Table 56. Trastuzumab Injection Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Trastuzumab Injection Distributors List
Table 59. Trastuzumab Injection Customer List
Table 60. Global Trastuzumab Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global Trastuzumab Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Trastuzumab Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas Trastuzumab Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Trastuzumab Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC Trastuzumab Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Trastuzumab Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe Trastuzumab Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Trastuzumab Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa Trastuzumab Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Trastuzumab Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global Trastuzumab Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Trastuzumab Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global Trastuzumab Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Pfizer Basic Information, Trastuzumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 75. Pfizer Trastuzumab Injection Product Portfolios and Specifications
Table 76. Pfizer Trastuzumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Pfizer Main Business
Table 78. Pfizer Latest Developments
Table 79. Roche Basic Information, Trastuzumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 80. Roche Trastuzumab Injection Product Portfolios and Specifications
Table 81. Roche Trastuzumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Roche Main Business
Table 83. Roche Latest Developments
Table 84. Celltrion Basic Information, Trastuzumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 85. Celltrion Trastuzumab Injection Product Portfolios and Specifications
Table 86. Celltrion Trastuzumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Celltrion Main Business
Table 88. Celltrion Latest Developments
Table 89. Amgen Basic Information, Trastuzumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 90. Amgen Trastuzumab Injection Product Portfolios and Specifications
Table 91. Amgen Trastuzumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Amgen Main Business
Table 93. Amgen Latest Developments
Table 94. Samsung Bioepsis Basic Information, Trastuzumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 95. Samsung Bioepsis Trastuzumab Injection Product Portfolios and Specifications
Table 96. Samsung Bioepsis Trastuzumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Samsung Bioepsis Main Business
Table 98. Samsung Bioepsis Latest Developments
Table 99. Mylan Basic Information, Trastuzumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 100. Mylan Trastuzumab Injection Product Portfolios and Specifications
Table 101. Mylan Trastuzumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Mylan Main Business
Table 103. Mylan Latest Developments
Table 104. Glenmark Basic Information, Trastuzumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 105. Glenmark Trastuzumab Injection Product Portfolios and Specifications
Table 106. Glenmark Trastuzumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Glenmark Main Business
Table 108. Glenmark Latest Developments
Table 109. AstraZeneca Basic Information, Trastuzumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 110. AstraZeneca Trastuzumab Injection Product Portfolios and Specifications
Table 111. AstraZeneca Trastuzumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. AstraZeneca Main Business
Table 113. AstraZeneca Latest Developments
Table 114. Remegen Co., Ltd. Basic Information, Trastuzumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 115. Remegen Co., Ltd. Trastuzumab Injection Product Portfolios and Specifications
Table 116. Remegen Co., Ltd. Trastuzumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Remegen Co., Ltd. Main Business
Table 118. Remegen Co., Ltd. Latest Developments
Table 119. Hisun Biopharmaceutical Basic Information, Trastuzumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 120. Hisun Biopharmaceutical Trastuzumab Injection Product Portfolios and Specifications
Table 121. Hisun Biopharmaceutical Trastuzumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Hisun Biopharmaceutical Main Business
Table 123. Hisun Biopharmaceutical Latest Developments
Table 124. Shanghai Henlius Biotech Basic Information, Trastuzumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 125. Shanghai Henlius Biotech Trastuzumab Injection Product Portfolios and Specifications
Table 126. Shanghai Henlius Biotech Trastuzumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Shanghai Henlius Biotech Main Business
Table 128. Shanghai Henlius Biotech Latest Developments
Table 1. Trastuzumab Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Trastuzumab Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 60 mg
Table 4. Major Players of 150 mg
Table 5. Major Players of 440 mg
Table 6. Major Players of Others
Table 7. Global Trastuzumab Injection Sales by Type (2021-2026) & (K Units)
Table 8. Global Trastuzumab Injection Sales Market Share by Type (2021-2026)
Table 9. Global Trastuzumab Injection Revenue by Type (2021-2026) & ($ million)
Table 10. Global Trastuzumab Injection Revenue Market Share by Type (2021-2026)
Table 11. Global Trastuzumab Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global Trastuzumab Injection Sale by Application (2021-2026) & (K Units)
Table 13. Global Trastuzumab Injection Sale Market Share by Application (2021-2026)
Table 14. Global Trastuzumab Injection Revenue by Application (2021-2026) & ($ million)
Table 15. Global Trastuzumab Injection Revenue Market Share by Application (2021-2026)
Table 16. Global Trastuzumab Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global Trastuzumab Injection Sales by Company (2021-2026) & (K Units)
Table 18. Global Trastuzumab Injection Sales Market Share by Company (2021-2026)
Table 19. Global Trastuzumab Injection Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Trastuzumab Injection Revenue Market Share by Company (2021-2026)
Table 21. Global Trastuzumab Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers Trastuzumab Injection Producing Area Distribution and Sales Area
Table 23. Players Trastuzumab Injection Products Offered
Table 24. Trastuzumab Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Trastuzumab Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global Trastuzumab Injection Sales Market Share Geographic Region (2021-2026)
Table 29. Global Trastuzumab Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Trastuzumab Injection Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Trastuzumab Injection Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global Trastuzumab Injection Sales Market Share by Country/Region (2021-2026)
Table 33. Global Trastuzumab Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Trastuzumab Injection Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Trastuzumab Injection Sales by Country (2021-2026) & (K Units)
Table 36. Americas Trastuzumab Injection Sales Market Share by Country (2021-2026)
Table 37. Americas Trastuzumab Injection Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Trastuzumab Injection Sales by Type (2021-2026) & (K Units)
Table 39. Americas Trastuzumab Injection Sales by Application (2021-2026) & (K Units)
Table 40. APAC Trastuzumab Injection Sales by Region (2021-2026) & (K Units)
Table 41. APAC Trastuzumab Injection Sales Market Share by Region (2021-2026)
Table 42. APAC Trastuzumab Injection Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Trastuzumab Injection Sales by Type (2021-2026) & (K Units)
Table 44. APAC Trastuzumab Injection Sales by Application (2021-2026) & (K Units)
Table 45. Europe Trastuzumab Injection Sales by Country (2021-2026) & (K Units)
Table 46. Europe Trastuzumab Injection Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Trastuzumab Injection Sales by Type (2021-2026) & (K Units)
Table 48. Europe Trastuzumab Injection Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa Trastuzumab Injection Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa Trastuzumab Injection Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Trastuzumab Injection Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa Trastuzumab Injection Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Trastuzumab Injection
Table 54. Key Market Challenges & Risks of Trastuzumab Injection
Table 55. Key Industry Trends of Trastuzumab Injection
Table 56. Trastuzumab Injection Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Trastuzumab Injection Distributors List
Table 59. Trastuzumab Injection Customer List
Table 60. Global Trastuzumab Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global Trastuzumab Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Trastuzumab Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas Trastuzumab Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Trastuzumab Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC Trastuzumab Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Trastuzumab Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe Trastuzumab Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Trastuzumab Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa Trastuzumab Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Trastuzumab Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global Trastuzumab Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Trastuzumab Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global Trastuzumab Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Pfizer Basic Information, Trastuzumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 75. Pfizer Trastuzumab Injection Product Portfolios and Specifications
Table 76. Pfizer Trastuzumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Pfizer Main Business
Table 78. Pfizer Latest Developments
Table 79. Roche Basic Information, Trastuzumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 80. Roche Trastuzumab Injection Product Portfolios and Specifications
Table 81. Roche Trastuzumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Roche Main Business
Table 83. Roche Latest Developments
Table 84. Celltrion Basic Information, Trastuzumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 85. Celltrion Trastuzumab Injection Product Portfolios and Specifications
Table 86. Celltrion Trastuzumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Celltrion Main Business
Table 88. Celltrion Latest Developments
Table 89. Amgen Basic Information, Trastuzumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 90. Amgen Trastuzumab Injection Product Portfolios and Specifications
Table 91. Amgen Trastuzumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Amgen Main Business
Table 93. Amgen Latest Developments
Table 94. Samsung Bioepsis Basic Information, Trastuzumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 95. Samsung Bioepsis Trastuzumab Injection Product Portfolios and Specifications
Table 96. Samsung Bioepsis Trastuzumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Samsung Bioepsis Main Business
Table 98. Samsung Bioepsis Latest Developments
Table 99. Mylan Basic Information, Trastuzumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 100. Mylan Trastuzumab Injection Product Portfolios and Specifications
Table 101. Mylan Trastuzumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Mylan Main Business
Table 103. Mylan Latest Developments
Table 104. Glenmark Basic Information, Trastuzumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 105. Glenmark Trastuzumab Injection Product Portfolios and Specifications
Table 106. Glenmark Trastuzumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Glenmark Main Business
Table 108. Glenmark Latest Developments
Table 109. AstraZeneca Basic Information, Trastuzumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 110. AstraZeneca Trastuzumab Injection Product Portfolios and Specifications
Table 111. AstraZeneca Trastuzumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. AstraZeneca Main Business
Table 113. AstraZeneca Latest Developments
Table 114. Remegen Co., Ltd. Basic Information, Trastuzumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 115. Remegen Co., Ltd. Trastuzumab Injection Product Portfolios and Specifications
Table 116. Remegen Co., Ltd. Trastuzumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Remegen Co., Ltd. Main Business
Table 118. Remegen Co., Ltd. Latest Developments
Table 119. Hisun Biopharmaceutical Basic Information, Trastuzumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 120. Hisun Biopharmaceutical Trastuzumab Injection Product Portfolios and Specifications
Table 121. Hisun Biopharmaceutical Trastuzumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Hisun Biopharmaceutical Main Business
Table 123. Hisun Biopharmaceutical Latest Developments
Table 124. Shanghai Henlius Biotech Basic Information, Trastuzumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 125. Shanghai Henlius Biotech Trastuzumab Injection Product Portfolios and Specifications
Table 126. Shanghai Henlius Biotech Trastuzumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Shanghai Henlius Biotech Main Business
Table 128. Shanghai Henlius Biotech Latest Developments
LIST OF FIGURES
Figure 1. Picture of Trastuzumab Injection
Figure 2. Trastuzumab Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Trastuzumab Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Trastuzumab Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Trastuzumab Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Trastuzumab Injection Sales Market Share by Country/Region (2025)
Figure 10. Trastuzumab Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 60 mg
Figure 12. Product Picture of 150 mg
Figure 13. Product Picture of 440 mg
Figure 14. Product Picture of Others
Figure 15. Global Trastuzumab Injection Sales Market Share by Type in 2026
Figure 16. Global Trastuzumab Injection Revenue Market Share by Type (2021-2026)
Figure 17. Trastuzumab Injection Consumed in Hospitals
Figure 18. Global Trastuzumab Injection Market: Hospitals (2021-2026) & (K Units)
Figure 19. Trastuzumab Injection Consumed in Clinics
Figure 20. Global Trastuzumab Injection Market: Clinics (2021-2026) & (K Units)
Figure 21. Trastuzumab Injection Consumed in Others
Figure 22. Global Trastuzumab Injection Market: Others (2021-2026) & (K Units)
Figure 23. Global Trastuzumab Injection Sale Market Share by Application (2025)
Figure 24. Global Trastuzumab Injection Revenue Market Share by Application in 2026
Figure 25. Trastuzumab Injection Sales by Company in 2026 (K Units)
Figure 26. Global Trastuzumab Injection Sales Market Share by Company in 2026
Figure 27. Trastuzumab Injection Revenue by Company in 2026 ($ millions)
Figure 28. Global Trastuzumab Injection Revenue Market Share by Company in 2026
Figure 29. Global Trastuzumab Injection Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Trastuzumab Injection Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Trastuzumab Injection Sales 2021-2026 (K Units)
Figure 32. Americas Trastuzumab Injection Revenue 2021-2026 ($ millions)
Figure 33. APAC Trastuzumab Injection Sales 2021-2026 (K Units)
Figure 34. APAC Trastuzumab Injection Revenue 2021-2026 ($ millions)
Figure 35. Europe Trastuzumab Injection Sales 2021-2026 (K Units)
Figure 36. Europe Trastuzumab Injection Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Trastuzumab Injection Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Trastuzumab Injection Revenue 2021-2026 ($ millions)
Figure 39. Americas Trastuzumab Injection Sales Market Share by Country in 2026
Figure 40. Americas Trastuzumab Injection Revenue Market Share by Country (2021-2026)
Figure 41. Americas Trastuzumab Injection Sales Market Share by Type (2021-2026)
Figure 42. Americas Trastuzumab Injection Sales Market Share by Application (2021-2026)
Figure 43. United States Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Trastuzumab Injection Sales Market Share by Region in 2026
Figure 48. APAC Trastuzumab Injection Revenue Market Share by Region (2021-2026)
Figure 49. APAC Trastuzumab Injection Sales Market Share by Type (2021-2026)
Figure 50. APAC Trastuzumab Injection Sales Market Share by Application (2021-2026)
Figure 51. China Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. India Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Trastuzumab Injection Sales Market Share by Country in 2026
Figure 59. Europe Trastuzumab Injection Revenue Market Share by Country (2021-2026)
Figure 60. Europe Trastuzumab Injection Sales Market Share by Type (2021-2026)
Figure 61. Europe Trastuzumab Injection Sales Market Share by Application (2021-2026)
Figure 62. Germany Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. France Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Trastuzumab Injection Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Trastuzumab Injection Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Trastuzumab Injection Sales Market Share by Application (2021-2026)
Figure 70. Egypt Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Trastuzumab Injection in 2026
Figure 76. Manufacturing Process Analysis of Trastuzumab Injection
Figure 77. Industry Chain Structure of Trastuzumab Injection
Figure 78. Channels of Distribution
Figure 79. Global Trastuzumab Injection Sales Market Forecast by Region (2027-2032)
Figure 80. Global Trastuzumab Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Trastuzumab Injection Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Trastuzumab Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Trastuzumab Injection Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Trastuzumab Injection Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Trastuzumab Injection
Figure 2. Trastuzumab Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Trastuzumab Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Trastuzumab Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Trastuzumab Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Trastuzumab Injection Sales Market Share by Country/Region (2025)
Figure 10. Trastuzumab Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 60 mg
Figure 12. Product Picture of 150 mg
Figure 13. Product Picture of 440 mg
Figure 14. Product Picture of Others
Figure 15. Global Trastuzumab Injection Sales Market Share by Type in 2026
Figure 16. Global Trastuzumab Injection Revenue Market Share by Type (2021-2026)
Figure 17. Trastuzumab Injection Consumed in Hospitals
Figure 18. Global Trastuzumab Injection Market: Hospitals (2021-2026) & (K Units)
Figure 19. Trastuzumab Injection Consumed in Clinics
Figure 20. Global Trastuzumab Injection Market: Clinics (2021-2026) & (K Units)
Figure 21. Trastuzumab Injection Consumed in Others
Figure 22. Global Trastuzumab Injection Market: Others (2021-2026) & (K Units)
Figure 23. Global Trastuzumab Injection Sale Market Share by Application (2025)
Figure 24. Global Trastuzumab Injection Revenue Market Share by Application in 2026
Figure 25. Trastuzumab Injection Sales by Company in 2026 (K Units)
Figure 26. Global Trastuzumab Injection Sales Market Share by Company in 2026
Figure 27. Trastuzumab Injection Revenue by Company in 2026 ($ millions)
Figure 28. Global Trastuzumab Injection Revenue Market Share by Company in 2026
Figure 29. Global Trastuzumab Injection Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Trastuzumab Injection Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Trastuzumab Injection Sales 2021-2026 (K Units)
Figure 32. Americas Trastuzumab Injection Revenue 2021-2026 ($ millions)
Figure 33. APAC Trastuzumab Injection Sales 2021-2026 (K Units)
Figure 34. APAC Trastuzumab Injection Revenue 2021-2026 ($ millions)
Figure 35. Europe Trastuzumab Injection Sales 2021-2026 (K Units)
Figure 36. Europe Trastuzumab Injection Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Trastuzumab Injection Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Trastuzumab Injection Revenue 2021-2026 ($ millions)
Figure 39. Americas Trastuzumab Injection Sales Market Share by Country in 2026
Figure 40. Americas Trastuzumab Injection Revenue Market Share by Country (2021-2026)
Figure 41. Americas Trastuzumab Injection Sales Market Share by Type (2021-2026)
Figure 42. Americas Trastuzumab Injection Sales Market Share by Application (2021-2026)
Figure 43. United States Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Trastuzumab Injection Sales Market Share by Region in 2026
Figure 48. APAC Trastuzumab Injection Revenue Market Share by Region (2021-2026)
Figure 49. APAC Trastuzumab Injection Sales Market Share by Type (2021-2026)
Figure 50. APAC Trastuzumab Injection Sales Market Share by Application (2021-2026)
Figure 51. China Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. India Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Trastuzumab Injection Sales Market Share by Country in 2026
Figure 59. Europe Trastuzumab Injection Revenue Market Share by Country (2021-2026)
Figure 60. Europe Trastuzumab Injection Sales Market Share by Type (2021-2026)
Figure 61. Europe Trastuzumab Injection Sales Market Share by Application (2021-2026)
Figure 62. Germany Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. France Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Trastuzumab Injection Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Trastuzumab Injection Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Trastuzumab Injection Sales Market Share by Application (2021-2026)
Figure 70. Egypt Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Trastuzumab Injection Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Trastuzumab Injection in 2026
Figure 76. Manufacturing Process Analysis of Trastuzumab Injection
Figure 77. Industry Chain Structure of Trastuzumab Injection
Figure 78. Channels of Distribution
Figure 79. Global Trastuzumab Injection Sales Market Forecast by Region (2027-2032)
Figure 80. Global Trastuzumab Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Trastuzumab Injection Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Trastuzumab Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Trastuzumab Injection Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Trastuzumab Injection Revenue Market Share Forecast by Application (2027-2032)
